Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,029.44, with a market capitalization of 987.12B. The stock trades at a price-to-earnings (P/E) ratio of 50.82 and offers a dividend yield of 58.4%.
As of 2025-12-15, Eli Lilly(LLY) stock has fluctuated between $1,003.50 and $1,029.93. The current price stands at $1,029.44, placing the stock +2.6% above today's low and -0.0% off the high.
Eli Lilly(LLY) shares are trading with a volume of 3.28M, against a daily average of 3.26M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Eli Lilly shares have climbed in the double digits this year. Generally, investors turn to pharmaceutical stocks to add an element of safety to their portfolio...
The European Medicines Agency’s, EMA, committee recommended a change to extend the use of Eli Lilly’s (LLY) Mounjaro for the treatment of type 2 diabetes, that...
Dow Jones Futures Loom For Divided Market; Tesla, Eli Lilly In Buy Areas 12/12/2025 Bears mauled AI stocks, but the Dow Jones and Russell 2000 hit new highs la...
Analyst ratings
74%
of 31 ratingsMore LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund l...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund l...
Key Points With its diverse product line, AbbVie is a terrific dividend stock with a solid underlying business. Eli Lilly is growing its top line incredibly r...
Wondering if Eli Lilly is still worth buying after its monster run, or if the upside has already been priced in? You are not alone, and that is exactly what thi...
Eli Lilly and Co. (NYSE:LLY) on Friday shared updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant) for previously treated breast cancer pat...
...
Eli Lilly (LLY) and Company announced updated results from the Phase 3 EMBER-3 study of Inluriyo, an oral estrogen receptor antagonist, in patients with estroge...